Search

Your search keyword '"Janssen, Harry L."' showing total 1,236 results

Search Constraints

Start Over You searched for: Author "Janssen, Harry L." Remove constraint Author: "Janssen, Harry L."
1,236 results on '"Janssen, Harry L."'

Search Results

1. A liver immune rheostat regulates CD8 T cell immunity in chronic HBV infection

2. Switching to tenofovir alafenamide in patients with virologically suppressed chronic hepatitis B and renal or hepatic impairment: final week 96 results from an open-label, multicentre, phase 2 study

4. Safety, pharmacodynamics, and antiviral activity of selgantolimod in viremic patients with chronic hepatitis B virus infection

5. HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy

6. Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial

7. A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook

8. Nomenclature of HBV core protein-targeting antivirals

9. B cell activation gene signature in blood and liver of HBeAg+ immune active chronic hepatitis B patients

11. Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial

12. Intrahepatic plasma cells, but not atypical memory B cells, associate with clinical phases of chronic hepatitis B

13. B cell activation gene signature in blood and liver of HBeAg+ immune active chronic hepatitis B patients

14. Graft Steatosis and Donor Diabetes Mellitus Additively Impact on Recipient Outcomes After Liver Transplantation—A European Registry Study.

15. Short-course, direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: a phase 3, single-centre, open-label study

17. Addition of PEG‐interferon to long‐term nucleos(t)ide analogue therapy enhances HBsAg decline and clearance in HBeAg‐negative chronic hepatitis B

19. Progression of the FIB-4 index among patients with chronic HCV infection and early liver disease

24. HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies

33. Single-cell RNA sequencing of liver fine-needle aspirates captures immune diversity in the blood and liver in chronic hepatitis B patients

34. Dissecting the multifaceted impact of statin use on fatty liver disease:A multidimensional study

35. Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

36. Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

41. Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection

43. Securing wider EU commitment to the elimination of hepatitis C virus

44. Brief Report: Effect of Antiretroviral Switch From Tenofovir Disoproxil fumarate to Tenofovir Alafenamide on Alanine Aminotransferase, Lipid Profiles, and Renal Function in HIV/HBV-Coinfected Individuals in a Nationwide Canadian Study

48. Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg ‐positive chronic hepatitis B

49. Hepatitis C virus‐specific immune responses following direct‐acting antivirals administered during recent hepatitis C virus infection

50. Early virologic relapse predicts alanine aminotransferase flares after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B

Catalog

Books, media, physical & digital resources